Increased let-7d-5p in non-alcoholic fatty liver promotes insulin resistance and is a potential blood biomarker for diagnosis.
Jorge Infante-MenéndezAndrea R López-PastorTamara González-IllanesPaula González-LópezRaquel Huertas-LárezEsther ReyÁgueda González-RodríguezCarmelo García-MonzónNikita P PatilMelina Vega de CénigaAaron B BakerAlmudena Gómez-HernándezOscar EscribanoPublished in: Liver international : official journal of the International Association for the Study of the Liver (2023)
Our results highlight the emerging role of let-7d-5p as a potential therapeutic target for NAFLD since its overexpression impairs hepatic insulin signalling, and also, as a novel non-invasive biomarker for NAFLD diagnosis.